Chuan Hsin Chang, MD
Internal Medicine · San Francisco
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 13
- 2 carriers
- Offices
- 3
- Since medical school
- 18 years
- R Franklin University of Med & Sci/Chicago Medical School, 2008
Offices
3 locations · North East Medical Services · County of San Mateo
Looking this up.
Hospitals listed: California Pacific Medical Center- Van Ness Campus · San Mateo Medical Center. That is not proof they admit you there this week.
Plans that list them
13 plans · 2 carriers
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Chang’s office at (415) 391-9686 to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
13 of 13 plans
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Harmony (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Silicon (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health the ONE (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| DualConnect (HMO D-SNP) | Santa Clara Family Health Plan | Listed | Sep 1, 2026 |
California Medical Board record
Licence A110086 · Current
Licensed to practise in California · since 2009 · expires 2027-11-30 · Rosalind Franklin University, the Chicago Medical School.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
School, training and certification
What this clinician told their state board, medical school and everything before it. Only some states publish this, so nothing here means the state does not say, not that there was no training or certification.
Specialty certification
- American Board of Internal Medicine - Endocrinology, Diabetes and Metabolism
- American Board of Internal Medicine - Internal Medicine
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- California Pacific Medical Center- Van Ness CampusSan Francisco, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Sutter Health, which runs 27 hospitals in 2 statesPatients rate it 4 of 5 · 78% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.224, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.325, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.373, Oct 2024 – Sep 2025
- San Mateo Medical CenterSan Mateo, CAAcute Care Hospital · Government - Local · Has an emergency departmentPart of San Mateo County HealthPatients rate it 3 of 5 · 68% would definitely recommend itNo overall ratingNo measure marked better or worse than the national rate
See every measure and the patient survey for California Pacific Medical Center- Van Ness Campus
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 1 better, 6 the same, 0 worse of 7 measures. Readmissions: 0 better, 8 the same, 2 worse of 10 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.224 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.325 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.373 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.14 (0.3 to 1.97) · 2,271 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.05 (0.81 to 1.28) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 192.86 (151.51 to 234.22) · 140 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.6 · 55 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.3 · 60 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 10.5 · 143 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.8 · 356 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 14.3 · 259 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 10.1 · 173 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.1 · 2,316 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.12 to 0.49) · 6,430 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.28 (0.09 to 0.47) · 7,168 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.3 (1.5 to 5.09) · 2,196 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 2.47 (1.21 to 3.74) · 925 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.63 (1.37 to 3.88) · 1,954 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 10.13 (6.06 to 14.2) · 1,112 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 7.26 (4.67 to 9.85) · 1,084 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.67 (0.31 to 3.03) · 832 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.33 (0 to 0.85) · 5,406 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0.443 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.717 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14.3 · 200 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 22.3 · 449 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 18.2 · 187 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 8.7 · 418 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 7.1 · 260 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 19.2 · 293 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.2 (3.6 to 7.6) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.2 (7.7 to 13.5) · 157 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for CABGUnplanned return visits | 11 · 33 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 20.2 · 66 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 12.5 (9.4 to 16.7) · 551 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 0.9 (0.7 to 1.3) · 219 cases | No different | Jan 2024 – Dec 2024 |
What patients said (478 patients answered, 20% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 4 |
| Quietness | 3 |
| Recommend hospital | 5 |
| Room was "always" clean | 75% |
| Nurses "always" communicated well | 74% |
| Doctors "always" communicated well | 77% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 88% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 71% |
| Doctors "always" listened carefully | 75% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 75% |
| Staff "always" explained new medications | 75% |
| Nurses "always" explained things so they could understand | 70% |
| Nurses "always" listened carefully | 71% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 53% |
| "YES", patients would definitely recommend the hospital | 78% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 88% |
See every measure and the patient survey for San Mateo Medical Center
Behind the star rating — Deaths: 0 better, 2 the same, 0 worse of 2 measures. Safety: 0 better, 2 the same, 0 worse of 2 measures. Readmissions: 0 better, 3 the same, 0 worse of 3 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.34 (0.25 to 2.43) · 45 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.97 (0.48 to 1.47) | No different | Jul 2022 – Jun 2024 |
| Death rate for pneumonia patientsComplications and deaths | 13.9 · 25 cases | None | Jul 2022 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 258 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.21 (0 to 0.44) · 379 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.26 (0.05 to 0.48) · 381 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.44 (0.82 to 6.05) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 2.64 (0.92 to 4.37) · 57 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.53 (0 to 1.76) · 296 cases | No different | Jul 2022 – Jun 2024 |
| Clostridium Difficile (C.Diff)Infections | 0.661 | No different | Oct 2024 – Sep 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.8 · 47 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -2.3 · 25 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 16.6 · 76 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 14 (10.4 to 18.9) · 167 cases | No different | Jan 2022 – Dec 2024 |
What patients said (208 patients answered, 15% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 3 |
| Communication about medicines | 3 |
| Discharge information | 4 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 3 |
| Room was "always" clean | 78% |
| Nurses "always" communicated well | 76% |
| Doctors "always" communicated well | 79% |
| Staff "always" explained | 62% |
| Yes, staff "did" give patients this information | 87% |
| Yes, staff "did" give patients information about help after discharge | 88% |
| Doctors "always" explained things so they could understand | 74% |
| Doctors "always" listened carefully | 77% |
| Doctors "always" treated them with courtesy and respect | 84% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 72% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 73% |
| Nurses "always" treated them with courtesy and respect | 82% |
| "Always" quiet at night | 47% |
| "YES", patients would definitely recommend the hospital | 68% |
| Staff "always" explained possible side effects | 51% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$7,728
Medicare paid this office $7,728 for 144 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Blood test, basic group of blood chemicals (calcium, total) | 106 | $1,492 | $8 |
| Hemoglobin a1c level | 81 | $1,457 | $10 |
| Insertion of needle into vein for collection of blood sample | 134 | $1,317 | $6 |
| Vitamin d-3 level | 34 | $1,247 | $29 |
| Blood test, thyroid stimulating hormone (tsh) | 31 | $1,136 | $16 |
See all 6 services
| Blood test, basic group of blood chemicals (calcium, total) | 106 | $1,492 | $8 |
| Hemoglobin a1c level | 81 | $1,457 | $10 |
| Insertion of needle into vein for collection of blood sample | 134 | $1,317 | $6 |
| Vitamin d-3 level | 34 | $1,247 | $29 |
| Blood test, thyroid stimulating hormone (tsh) | 31 | $1,136 | $16 |
| Thyroxine (thyroid chemical), free | 31 | $610 | $9 |
Who their Medicare patients are
144 Original Medicare patients in 2024. Average age 73 · Women 61% · Health risk score 1.01. At or below the middle of the specialty; the typical internal medicine clinician is at 1.76.
Conditions among them: High blood pressure 74% · Diabetes 68% · Chronic kidney disease 33% · COPD 8% · Atrial fibrillation 8% · Depression 8% · Dementia 8%.
The office billed $19,663, Medicare allowed $7,807 and paid $7,728; for 755 services of 14 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 144 | 755 | 73 | 1.01 | $19,663 | $7,728 |
| 2023 | 132 | 620 | 73 | 0.88 | $15,883 | $5,961 |
| 2022 | 204 | 897 | 73 | 0.82 | $20,544 | $7,701 |
| 2021 | 238 | 1,102 | 73 | 1.02 | $24,354 | $9,812 |
| 2020 | 162 | 743 | 72 | 1.12 | $16,238 | $6,457 |
| 2019 | 190 | 771 | 72 | 1.02 | $17,073 | $7,450 |
| 2018 | 118 | 468 | 71 | 1.00 | $10,600 | $5,189 |
| 2017 | 88 | 323 | 71 | 1.16 | $6,710 | $3,631 |
| 2016 | 73 | 313 | 71 | 0.98 | $7,343 | $4,077 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 6 services
| Blood test, basic group of blood chemicals (calcium, total) | 99 | $1,368 | $8 |
| Hemoglobin a1c level | 78 | $1,333 | $10 |
| Blood test, thyroid stimulating hormone (tsh) | 27 | $988 | $16 |
| Insertion of needle into vein for collection of blood sample | 108 | $958 | $6 |
| Vitamin d-3 level | 21 | $696 | $29 |
| Thyroxine (thyroid chemical), free | 27 | $530 | $9 |
2022: 6 services
| Blood test, thyroid stimulating hormone (tsh) | 61 | $1,810 | $17 |
| Blood test, basic group of blood chemicals (calcium, total) | 137 | $1,791 | $8 |
| Hemoglobin a1c level | 106 | $1,680 | $10 |
| Thyroxine (thyroid chemical), free | 59 | $963 | $9 |
| Insertion of needle into vein for collection of blood sample | 175 | $774 | $3 |
| Vitamin d-3 level | 17 | $586 | $29 |
2021: 6 services
| Blood test, thyroid stimulating hormone (tsh) | 61 | $2,402 | $17 |
| Blood test, basic group of blood chemicals (calcium, total) | 172 | $2,149 | $8 |
| Hemoglobin a1c level | 120 | $1,787 | $10 |
| Thyroxine (thyroid chemical), free | 61 | $1,281 | $9 |
| Insertion of needle into vein for collection of blood sample | 203 | $996 | $3 |
| Vitamin d-3 level | 17 | $651 | $30 |
2020: 6 services
| Blood test, thyroid stimulating hormone (tsh) | 43 | $1,639 | $17 |
| Blood test, basic group of blood chemicals (calcium, total) | 118 | $1,457 | $8 |
| Hemoglobin a1c level | 89 | $1,286 | $10 |
| Thyroxine (thyroid chemical), free | 43 | $862 | $9 |
| Insertion of needle into vein for collection of blood sample | 135 | $624 | $3 |
| Vitamin d-3 level | 12 | $413 | $29 |
2019: 6 services
| Blood test, thyroid stimulating hormone (tsh) | 55 | $1,812 | $18 |
| Blood test, basic group of blood chemicals (calcium, total) | 139 | $1,704 | $9 |
| Hemoglobin a1c level | 84 | $1,142 | $11 |
| Vitamin d-3 level | 24 | $1,031 | $32 |
| Thyroxine (thyroid chemical), free | 52 | $943 | $10 |
| Insertion of needle into vein for collection of blood sample | 169 | $688 | $3 |
2018: 6 services
| Blood test, thyroid stimulating hormone (tsh) | 37 | $1,281 | $20 |
| Vitamin d-3 level | 24 | $1,075 | $36 |
| Blood test, basic group of blood chemicals (calcium, total) | 66 | $859 | $10 |
| Hemoglobin a1c level | 45 | $658 | $12 |
| Thyroxine (thyroid chemical), free | 29 | $611 | $11 |
| Insertion of needle into vein for collection of blood sample | 99 | $426 | $3 |
2017: 9 services
| Blood test, thyroid stimulating hormone (tsh) | 29 | $1,107 | $23 |
| Thyroxine (thyroid chemical), free | 29 | $594 | $12 |
| Vitamin d-3 level | 14 | $557 | $40 |
| Hemoglobin a1c level | 27 | $392 | $13 |
| Blood test, basic group of blood chemicals (calcium, total) | 25 | $276 | $10 |
| Insertion of needle into vein for collection of blood sample | 66 | $241 | $3 |
| Urine calcium level | 20 | $162 | $8 |
| Urine volume measurement | 20 | $89 | $4 |
| Creatinine level to test for kidney function or muscle injury | 12 | $84 | $7 |
2016: 8 services
| Vitamin d-3 level | 15 | $790 | $40 |
| Blood test, thyroid stimulating hormone (tsh) | 19 | $785 | $22 |
| Hemoglobin a1c level | 29 | $505 | $13 |
| Thyroxine (thyroid chemical), free | 19 | $421 | $12 |
| Insertion of needle into vein for collection of blood sample | 61 | $273 | $3 |
| Blood test, basic group of blood chemicals (calcium, total) | 13 | $162 | $10 |
| Urine calcium level | 11 | $145 | $8 |
| Urine volume measurement | 12 | $88 | $4 |
Medicaid work
$348,301 in 2024
Medicaid paid $348,301 for 7,754 billed services this clinician did in 2024, up to 120 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 1,590 | $275,220 |
| Return visit (30+ min) | 1,179 | $45,187 |
| Short return visit (20+ min) | 1,772 | $25,095 |
| Thyroid stimulating hormone (TSH) | 40 | $898 |
| Hemoglobin A1C level | 105 | $684 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 107 | $675 |
| Measurement of free thyroxine | 40 | $480 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 584 | $62 |
| BODY MASS INDEX DOCD | 827 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 536 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 111 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 25 | $0 |
| 2024 | 7,754 | 15 | 120 | $348,301 |
| 2023 | 5,836 | 15 | 144 | $307,281 |
| 2022 | 5,144 | 14 | 114 | $238,666 |
| 2021 | 8,753 | 12 | 203 | $488,644 |
| 2020 | 6,628 | 10 | 187 | $380,702 |
| 2019 | 5,276 | 9 | 146 | $249,642 |
| 2018 | 4,063 | 7 | 154 | $303,958 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 1,671 | $271,292 |
| Short return visit (20+ min) | 2,123 | $19,106 |
| Return visit (30+ min) | 789 | $12,372 |
| New patient visit (45+ min) | 14 | $1,688 |
| Thyroid stimulating hormone (TSH) | 51 | $1,077 |
| Hemoglobin A1C level | 117 | $681 |
| Measurement of free thyroxine | 51 | $577 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 59 | $449 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 387 | $40 |
| BODY MASS INDEX DOCD | 117 | $0 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 176 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 18 | $0 |
2022
| Clinic visit/encounter, all-inclusive | 1,309 | $213,630 |
| Short return visit (20+ min) | 1,729 | $9,689 |
| Return visit (30+ min) | 994 | $9,614 |
| New patient visit (45+ min) | 45 | $4,899 |
| Thyroid stimulating hormone (TSH) | 13 | $259 |
| Hemoglobin A1C level | 27 | $194 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 29 | $193 |
| Measurement of free thyroxine | 13 | $139 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 339 | $49 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 225 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 43 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 39 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 2,507 | $477,967 |
| Short return visit (20+ min) | 3,497 | $6,486 |
| Return visit (30+ min) | 838 | $2,513 |
| Thyroid stimulating hormone (TSH) | 56 | $1,028 |
| Measurement of free thyroxine | 56 | $539 |
| Basic metabolic panel (Calcium, total) This panel must include the following: Calcium, total (82310) Carbon dioxide (bicarbonate) (82374) Chloride (82435) Creatinine (82565) Glucose (82947) Potassium (84132) Sodium (84295) Urea nitrogen (BUN) (84520) | 14 | $59 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 616 | $51 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 382 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 63 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 143 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 568 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 2,251 | $373,886 |
| Short return visit (20+ min) | 3,571 | $5,391 |
| Return visit (30+ min) | 270 | $601 |
| Thyroid stimulating hormone (TSH) | 26 | $532 |
| Measurement of free thyroxine | 25 | $285 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 208 | $7 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 97 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 13 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 13 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 154 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 1,580 | $247,065 |
| Short return visit (20+ min) | 1,972 | $2,259 |
| Return visit (30+ min) | 387 | $289 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 559 | $29 |
| Most recent systolic blood pressure less than 130 mm Hg (DM) (HTN, CKD, CAD) | 269 | $0 |
| Most recent systolic blood pressure 130-139 mm Hg (DM) (HTN, CKD, CAD) | 60 | $0 |
| Most recent systolic blood pressure greater than or equal to 140 mm Hg (HTN, CKD, CAD) (DM) | 62 | $0 |
| Most recent diastolic blood pressure less than 80 mm Hg (HTN, CKD, CAD) (DM) | 332 | $0 |
| Most recent diastolic blood pressure 80-89 mm Hg (HTN, CKD, CAD) (DM) | 55 | $0 |
2018
| Clinic visit/encounter, all-inclusive | 1,951 | $302,406 |
| Short return visit (20+ min) | 1,408 | $947 |
| Return visit (30+ min) | 306 | $513 |
| Short return visit | 191 | $77 |
| Glucose, blood by glucose monitoring device(s) cleared by the FDA specifically for home use | 171 | $11 |
| Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections); 1 vaccine (single or combination vaccine/toxoid) | 20 | $4 |
| Influenza virus vaccine, quadrivalent (ccIIV4), derived from cell cultures, subunit, antibiotic free, 0.5 mL dosage, for intramuscular use | 16 | $0 |
Drugs they prescribed that Part D paid
$1,418,253
Pharmacies billed $1,418,253 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 0% of their Part D prescriptions (0 of 2,374) in 2024. At or below the middle of the specialty; the typical internal medicine clinician is at 1%.
785 generic and 1,375 brand-name prescriptions · $1,418,253 in drug cost.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Jardiance | 216 | $314,384 | $1,455 |
| Trulicity | 159 | $244,032 | $1,535 |
| Januvia | 140 | $193,652 | $1,383 |
| Ozempic | 101 | $117,310 | $1,161 |
| Prolia | 57 | $86,521 | $1,518 |
See all 40 drugs
| Jardiance | 216 | $314,384 | $1,455 |
| Trulicity | 159 | $244,032 | $1,535 |
| Januvia | 140 | $193,652 | $1,383 |
| Ozempic | 101 | $117,310 | $1,161 |
| Prolia | 57 | $86,521 | $1,518 |
| Tradjenta | 60 | $69,505 | $1,158 |
| Rybelsus | 30 | $56,600 | $1,887 |
| Invokana | 42 | $47,477 | $1,130 |
| Basaglar Kwikpen U-100 | 97 | $38,527 | $397 |
| Farxiga | 24 | $34,632 | $1,443 |
| Victoza 3-Pak | 19 | $23,304 | $1,227 |
| Teriparatide | 11 | $20,801 | $1,891 |
| Fiasp Flextouch | 21 | $18,933 | $902 |
| Novolog Mix 70-30 Flexpen | 29 | $7,010 | $242 |
| Insulin Lispro Kwikpen U-100 | 26 | $6,652 | $256 |
| Lantus Solostar | 55 | $6,360 | $116 |
| Insulin Glargine-Yfgn | 41 | $6,069 | $148 |
| Insulin Aspart Flexpen | 17 | $4,766 | $280 |
| Ultra-Fine Mini Pen Needle | 58 | $4,370 | $75 |
| Toujeo Solostar | 14 | $4,030 | $288 |
| Novolog Flexpen | 23 | $3,818 | $166 |
| Humalog Kwikpen U-100 | 12 | $2,965 | $247 |
| Metformin | 242 | $2,655 | $11 |
| Comfort Ez Pen Needle | 20 | $2,345 | $117 |
| Humalog Mix 75-25 Kwikpen | 11 | $2,193 | $199 |
| Insulin Aspart Prot Mix 70-30 | 15 | $2,052 | $137 |
| Ultra-Fine Nano Pen Needle | 21 | $1,841 | $88 |
| Methimazole | 82 | $1,580 | $19 |
| Novolin 70-30 Flexpen | 13 | $1,564 | $120 |
| Glipizide | 121 | $1,462 | $12 |
| Techlite Pen Needle | 50 | $1,404 | $28 |
| Nano 2nd Gen Pen Needle | 13 | $982 | $76 |
| Trueplus Pen Needle | 25 | $966 | $39 |
| Propylthiouracil | 13 | $867 | $67 |
| Alendronate | 95 | $775 | $8 |
| Glipizide Er | 37 | $742 | $20 |
| Levothyroxine | 54 | $650 | $12 |
| Metformin Hcl Er | 40 | $608 | $15 |
| Pioglitazone | 28 | $301 | $11 |
| Glimepiride | 22 | $196 | $9 |
Year by year
| 2024 | 2,374 | 328 | 0% (0) | 58% | $1,418,253 |
| 2023 | 1,993 | 293 | 0% (0) | 59% | $1,434,656 |
| 2022 | 2,110 | 352 | 0% (0) | 56% | $1,323,034 |
| 2021 | 2,584 | 363 | 0% (0) | 58% | $1,519,042 |
| 2020 | 2,107 | 282 | 0% (0) | 57% | $1,178,276 |
| 2019 | 1,790 | 259 | None | 60% | $897,356 |
| 2018 | 1,074 | 172 | 0% (0) | 57% | $527,531 |
| 2017 | 782 | 117 | 0% (0) | 57% | $377,095 |
| 2016 | 435 | 75 | 0% (0) | 55% | $166,848 |
| 2015 | 129 | 31 | 0% (0) | 61% | $62,396 |
| 2014 | 69 | 20 | None | 48% | $9,676 |
| 2013 | 111 | 43 | None | 30% | $10,527 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 29 drugs
| Jardiance | 152 | $271,502 | $1,786 |
| Januvia | 162 | $243,646 | $1,504 |
| Trulicity | 157 | $204,814 | $1,305 |
| Victoza 3-Pak | 59 | $112,497 | $1,907 |
| Novolog Flexpen | 62 | $91,183 | $1,471 |
| Tradjenta | 61 | $82,351 | $1,350 |
| Prolia | 45 | $74,492 | $1,655 |
| Novolog Mix 70-30 Flexpen | 47 | $56,533 | $1,203 |
| Basaglar Kwikpen U-100 | 119 | $52,968 | $445 |
| Invokana | 22 | $38,237 | $1,738 |
| Lantus Solostar | 57 | $30,870 | $542 |
| Farxiga | 13 | $21,395 | $1,646 |
| Humalog Kwikpen U-100 | 17 | $17,472 | $1,028 |
| Insulin Glargine-Yfgn | 42 | $8,251 | $196 |
| Novolin R | 13 | $7,112 | $547 |
| Insulin Lispro Kwikpen U-100 | 20 | $5,658 | $283 |
| Metformin | 207 | $4,233 | $20 |
| Techlite Pen Needle | 106 | $3,767 | $36 |
| Trueplus Pen Needle | 77 | $2,676 | $35 |
| Glipizide | 95 | $1,934 | $20 |
| Methimazole | 72 | $1,511 | $21 |
| Nano 2nd Gen Pen Needle | 12 | $1,495 | $125 |
| Metformin Hcl Er | 40 | $1,385 | $35 |
| Alendronate | 60 | $1,373 | $23 |
| Levothyroxine | 29 | $883 | $30 |
| Testosterone Cypionate | 16 | $812 | $51 |
| Glipizide Er | 12 | $398 | $33 |
| Glimepiride | 12 | $316 | $26 |
| Pioglitazone | 12 | $253 | $21 |
2022: 32 drugs
| Januvia | 159 | $225,816 | $1,420 |
| Jardiance | 92 | $148,828 | $1,618 |
| Novolog Flexpen | 111 | $148,455 | $1,337 |
| Victoza 3-Pak | 62 | $133,088 | $2,147 |
| Trulicity | 77 | $99,447 | $1,292 |
| Prolia | 67 | $97,643 | $1,457 |
| Novolog Mix 70-30 Flexpen | 83 | $87,932 | $1,059 |
| Tradjenta | 54 | $70,542 | $1,306 |
| Lantus Solostar | 114 | $57,465 | $504 |
| Basaglar Kwikpen U-100 | 118 | $52,356 | $444 |
| Invokana | 25 | $26,885 | $1,075 |
| Farxiga | 14 | $19,782 | $1,413 |
| Ozempic | 17 | $15,907 | $936 |
| Novolin 70-30 | 15 | $15,303 | $1,020 |
| Lantus | 11 | $13,595 | $1,236 |
| Humalog Kwikpen U-100 | 11 | $9,605 | $873 |
| Novolin R | 12 | $7,453 | $621 |
| Trueplus Pen Needle | 162 | $5,706 | $35 |
| Comfort Ez Pen Needle | 35 | $4,592 | $131 |
| Novolin 70-30 Flexpen | 11 | $4,149 | $377 |
| Novolin N Flexpen | 14 | $3,817 | $273 |
| Sure Comfort Pen Needle | 50 | $3,409 | $68 |
| Metformin | 212 | $2,570 | $12 |
| Techlite Pen Needle | 72 | $2,253 | $31 |
| Glipizide | 102 | $1,310 | $13 |
| Levothyroxine | 44 | $1,104 | $25 |
| Metformin Hcl Er | 28 | $711 | $25 |
| Alendronate | 45 | $658 | $15 |
| Methimazole | 64 | $655 | $10 |
| Unifine Pentips | 14 | $492 | $35 |
| Glipizide Xl | 12 | $424 | $35 |
| Pioglitazone | 12 | $282 | $24 |
2021: 37 drugs
| Januvia | 215 | $298,982 | $1,391 |
| Jardiance | 105 | $163,170 | $1,554 |
| Victoza 3-Pak | 72 | $130,790 | $1,817 |
| Novolog Flexpen | 107 | $123,529 | $1,154 |
| Trulicity | 93 | $103,490 | $1,113 |
| Novolog Mix 70-30 Flexpen | 99 | $102,217 | $1,032 |
| Prolia | 65 | $86,613 | $1,333 |
| Basaglar Kwikpen U-100 | 167 | $81,903 | $490 |
| Tradjenta | 56 | $64,922 | $1,159 |
| Lantus Solostar | 94 | $49,076 | $522 |
| Invokana | 31 | $35,153 | $1,134 |
| Novolin 70-30 | 18 | $23,543 | $1,308 |
| Humalog Kwikpen U-100 | 29 | $22,541 | $777 |
| Lantus | 23 | $20,600 | $896 |
| Onglyza | 14 | $17,023 | $1,216 |
| Humalog Mix 75-25 Kwikpen | 16 | $14,662 | $916 |
| Humulin 70/30 Kwikpen | 18 | $12,635 | $702 |
| Comfort Ez Pen Needle | 80 | $12,302 | $154 |
| Sure Comfort | 189 | $10,189 | $54 |
| Levemir Flextouch | 14 | $10,071 | $719 |
| Insulin Aspart Prot Mix 70-30 | 19 | $9,577 | $504 |
| Novolin 70-30 Flexpen | 22 | $7,064 | $321 |
| Novolin N Flexpen | 17 | $3,567 | $210 |
| Trueplus Pen Needle | 65 | $2,629 | $40 |
| Glipizide-Metformin | 19 | $2,120 | $112 |
| Metformin | 248 | $1,973 | $8 |
| Levothyroxine | 60 | $1,397 | $23 |
| Insulin | 21 | $1,285 | $61 |
| Acarbose | 14 | $1,224 | $87 |
| Glipizide | 133 | $1,163 | $9 |
| Methimazole | 94 | $1,128 | $12 |
| Insulin | 20 | $995 | $50 |
| Ultra-Fine Short Pen Needle | 11 | $839 | $76 |
| Glipizide Xl | 18 | $522 | $29 |
| Alendronate | 43 | $414 | $10 |
| Pioglitazone | 16 | $356 | $22 |
| Metformin Hcl Er | 27 | $279 | $10 |
2020: 35 drugs
| Januvia | 206 | $272,809 | $1,324 |
| Jardiance | 85 | $129,897 | $1,528 |
| Victoza 3-Pak | 88 | $126,530 | $1,438 |
| Novolog Flexpen | 89 | $113,724 | $1,278 |
| Novolog Mix 70-30 Flexpen | 85 | $76,538 | $900 |
| Trulicity | 57 | $62,725 | $1,100 |
| Basaglar Kwikpen U-100 | 94 | $52,609 | $560 |
| Prolia | 39 | $50,206 | $1,287 |
| Tradjenta | 32 | $34,630 | $1,082 |
| Lantus Solostar | 71 | $33,959 | $478 |
| Invokana | 26 | $26,585 | $1,022 |
| Humalog Mix 75-25 Kwikpen | 20 | $18,028 | $901 |
| Humulin 70/30 Kwikpen | 27 | $17,951 | $665 |
| Novolin 70-30 | 18 | $15,836 | $880 |
| Sure Comfort | 246 | $11,621 | $47 |
| Levemir Flextouch | 14 | $10,275 | $734 |
| Lantus | 13 | $7,807 | $601 |
| Humalog Kwikpen U-100 | 12 | $6,797 | $566 |
| Humulin N Kwikpen | 13 | $6,422 | $494 |
| Novolin 70-30 Flexpen | 19 | $6,194 | $326 |
| Humulin R | 13 | $2,052 | $158 |
| Glipizide-Metformin | 18 | $1,915 | $106 |
| Levothyroxine | 66 | $1,584 | $24 |
| Metformin | 187 | $1,428 | $8 |
| Acarbose | 22 | $1,118 | $51 |
| Methimazole | 76 | $1,049 | $14 |
| Glipizide | 110 | $1,042 | $9 |
| Ultra-Fine Mini Pen Needle | 11 | $1,006 | $91 |
| Ultra-Fine Nano Pen Needle | 11 | $861 | $78 |
| Glipizide Xl | 11 | $497 | $45 |
| Trueplus Pen Needle | 18 | $491 | $27 |
| Alendronate | 42 | $460 | $11 |
| Insulin | 15 | $421 | $28 |
| Metformin Hcl Er | 32 | $375 | $12 |
| Insulin | 11 | $344 | $31 |
2019: 32 drugs
| Januvia | 166 | $188,233 | $1,134 |
| Jardiance | 63 | $79,325 | $1,259 |
| Victoza 3-Pak | 77 | $72,925 | $947 |
| Prolia | 59 | $72,756 | $1,233 |
| Novolog Mix 70-30 Flexpen | 94 | $66,591 | $708 |
| Novolog Flexpen | 60 | $59,056 | $984 |
| Trulicity | 47 | $41,993 | $893 |
| Basaglar Kwikpen U-100 | 83 | $38,396 | $463 |
| Tradjenta | 30 | $35,479 | $1,183 |
| Lantus Solostar | 79 | $34,566 | $438 |
| Humalog Kwikpen U-200 | 18 | $27,963 | $1,554 |
| Invokana | 24 | $15,260 | $636 |
| Humulin 70/30 Kwikpen | 27 | $14,577 | $540 |
| Toujeo Solostar | 17 | $14,572 | $857 |
| Novolog Mix 70-30 | 13 | $14,309 | $1,101 |
| Novolin 70-30 | 17 | $14,227 | $837 |
| Sure Comfort | 220 | $9,084 | $41 |
| Levemir Flextouch | 14 | $9,008 | $643 |
| Novolin N | 13 | $5,211 | $401 |
| Humulin 70-30 | 14 | $2,791 | $199 |
| Levothyroxine | 64 | $1,595 | $25 |
| Metformin | 120 | $1,069 | $9 |
| Glipizide-Metformin | 18 | $1,027 | $57 |
| Ultra-Fine Mini Pen Needle | 13 | $997 | $77 |
| Acarbose | 16 | $940 | $59 |
| Methimazole | 60 | $884 | $15 |
| Glipizide | 84 | $590 | $7 |
| Trueplus Pen Needle | 18 | $520 | $29 |
| Insulin | 16 | $396 | $25 |
| Metformin Hcl Er | 31 | $367 | $12 |
| Alendronate | 30 | $345 | $12 |
| Pioglitazone | 14 | $257 | $18 |
2018: 24 drugs
| Januvia | 99 | $121,433 | $1,227 |
| Forteo | 14 | $59,166 | $4,226 |
| Novolog Flexpen | 62 | $54,617 | $881 |
| Victoza 3-Pak | 48 | $52,422 | $1,092 |
| Lantus Solostar | 77 | $41,276 | $536 |
| Novolog Mix 70-30 Flexpen | 30 | $23,732 | $791 |
| Humalog Kwikpen U-200 | 15 | $23,037 | $1,536 |
| Tradjenta | 18 | $19,457 | $1,081 |
| Prolia | 14 | $15,895 | $1,135 |
| Basaglar Kwikpen U-100 | 40 | $14,998 | $375 |
| Novolin 70-30 | 21 | $13,189 | $628 |
| Invokana | 16 | $13,099 | $819 |
| Humalog Kwikpen U-100 | 11 | $8,900 | $809 |
| Levemir Flextouch | 17 | $8,649 | $509 |
| Sure Comfort | 137 | $5,899 | $43 |
| Novolin N | 18 | $5,137 | $285 |
| Ultra-Fine Mini Pen Needle | 13 | $1,199 | $92 |
| Levothyroxine | 39 | $1,168 | $30 |
| Metformin | 80 | $827 | $10 |
| Methimazole | 39 | $667 | $17 |
| Glipizide | 51 | $422 | $8 |
| Insulin | 18 | $368 | $20 |
| Alendronate | 37 | $315 | $9 |
| Metformin Hcl Er | 27 | $214 | $8 |
2017: 17 drugs
| Januvia | 105 | $110,796 | $1,055 |
| Novolog Flexpen | 51 | $45,896 | $900 |
| Lantus Solostar | 91 | $39,028 | $429 |
| Victoza 3-Pak | 24 | $19,358 | $807 |
| Onglyza | 12 | $12,295 | $1,025 |
| Novolin 70-30 | 15 | $12,037 | $802 |
| Novolog Mix 70-30 Flexpen | 14 | $11,564 | $826 |
| Humalog Kwikpen U-100 | 14 | $9,333 | $667 |
| Levemir Flextouch | 14 | $7,416 | $530 |
| Invokana | 13 | $6,519 | $501 |
| Sure Comfort | 112 | $4,448 | $40 |
| Acarbose | 14 | $749 | $53 |
| Levothyroxine | 22 | $732 | $33 |
| Metformin | 56 | $605 | $11 |
| Pioglitazone | 18 | $337 | $19 |
| Glipizide | 29 | $260 | $9 |
| Methimazole | 14 | $187 | $13 |
2016: 9 drugs
| Januvia | 56 | $49,182 | $878 |
| Lantus Solostar | 60 | $26,096 | $435 |
| Novolog Flexpen | 21 | $16,730 | $797 |
| Lantus | 17 | $9,484 | $558 |
| Novolin 70-30 | 11 | $7,087 | $644 |
| Sure Comfort | 69 | $2,131 | $31 |
| Metformin | 34 | $271 | $8 |
| Metformin Hcl Er | 15 | $195 | $13 |
| Glipizide | 17 | $171 | $10 |
2015: 2 drugs
| Hydrocortisone | 14 | $501 | $36 |
| Levothyroxine | 14 | $354 | $25 |
2014: 1 drug
| Hydrocortisone | 17 | $611 | $36 |
Money from drug and device companies
$33 in 2022
| 2022 | 1 | 1 | None | $33 |
| 2019 | 2 | 2 | None | $97 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Baxter Healthcare | None | $33 | 1 payment
|
See the published payment
| Baxter Healthcare | Debt forgiveness · 2022-04-01 | None | $33 |
See earlier years (2019)
2019: $97
| Merck Sharp & Dohme | Pneumovax 23 | $73 | 1 payment
|
| Relypsa | Veltassa | $24 | 1 payment
|
Professional record
- NPI
- 1033377841
- Licence
- CA A110086California A110086: Current · expires 2027-11-30
- Trained
- R Franklin University of Med & Sci/Chicago Medical School, 2008 · 18 years ago
- Group
- North East Medical Services · County of San Mateo
- Gender
- Female
More record details
- Sole proprietor
- No
- Taxonomy
- Federal specialty code 207RE0101X (207RE0101X); Internal medicine (207R00000X); Student in a training program (390200000X)
- Mailing address
- 1520 Stockton St, San Francisco, CA, 94133
- NPI first listed
- 2008-05-28
- NPI last updated
- 2017-01-18
This is when the NPI record was last certified, not a medical board exam.